Platinum Based Chemotherapy Risk Factors | Medical Algorithm

Are you evaluating a patient being treated with cisplatin or other platinum-based chemotherapy?

Yes

Has/Does the patient?

• been treated with a high dose platinum-based regimen?

Yes

• have a history of previous cranial irradiation?

Yes

• have anemia?

Yes

• have low serum protein?

Yes

• been treated concurrently with other ototoxic drugs?

Yes

• have concurrent middle ear disease?

Yes

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of risk factors for hearing loss after the chemotherapy

The risk of hearing loss is probably

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Risk Factors for Radiation Retinopathy
- Choroidal Melanoma | Intraocular Irradiation Risk Factors for Papillopathy & Maculopathy
Clinical Diagnosis, Including Family History For Genetics
- Clinical Features of Radiation Retinopathy
- Clinical Features of Radiation Optic Neuropathy
Criteria For Diagnosis
- Classification for Grading Hearing Loss in Child Treated with Cisplatin

Monitoring

Response To Therapy
Adverse Effects
- Risk Factors for Radiation Retinopathy
- Classification for Grading Hearing Loss in Child Treated with Cisplatin
Complication Detection

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Monitoring

Specialty

Objective

ICD-10

Platinum-Based Chemotherapy | Risk Factors for Hearing Loss

Purpose: To identify risk factors for hearing loss in a patient treated with cisplatin or other platinum-based chemotherapy.

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Monitoring

Specialty

Objective

ICD-10